Correlation Between MediciNova and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MediciNova and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on MediciNova and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Arrowhead Pharmaceuticals.

Diversification Opportunities for MediciNova and Arrowhead Pharmaceuticals

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between MediciNova and Arrowhead is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of MediciNova i.e., MediciNova and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between MediciNova and Arrowhead Pharmaceuticals

Given the investment horizon of 90 days MediciNova is expected to generate 1.08 times less return on investment than Arrowhead Pharmaceuticals. In addition to that, MediciNova is 1.05 times more volatile than Arrowhead Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest  2,551  in Arrowhead Pharmaceuticals on November 28, 2024 and sell it today you would lose (585.00) from holding Arrowhead Pharmaceuticals or give up 22.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

MediciNova  vs.  Arrowhead Pharmaceuticals

 Performance 
       Timeline  
MediciNova 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days MediciNova has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

MediciNova and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MediciNova and Arrowhead Pharmaceuticals

The main advantage of trading using opposite MediciNova and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind MediciNova and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals